Colonial Trust Advisors Reduces Stake in Zoetis Inc. $ZTS

Colonial Trust Advisors cut its position in shares of Zoetis Inc. (NYSE:ZTS) by 20.0% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,774 shares of the company’s stock after selling 5,930 shares during the quarter. Colonial Trust Advisors’ holdings in Zoetis were worth $3,479,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the company. Halbert Hargrove Global Advisors LLC raised its stake in shares of Zoetis by 496.6% during the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after buying an additional 144 shares during the last quarter. NewSquare Capital LLC increased its holdings in Zoetis by 69.1% during the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after acquiring an additional 85 shares in the last quarter. Financial Consulate Inc. acquired a new position in Zoetis during the third quarter worth about $39,000. SJS Investment Consulting Inc. raised its position in Zoetis by 1,606.3% during the third quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after acquiring an additional 257 shares during the last quarter. Finally, TruNorth Capital Management LLC purchased a new stake in shares of Zoetis in the third quarter valued at about $42,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Barclays assumed coverage on shares of Zoetis in a research note on Monday, December 8th. They set an “equal weight” rating and a $136.00 price objective for the company. UBS Group set a $136.00 price target on Zoetis in a research report on Thursday, January 29th. Morgan Stanley set a $160.00 price target on Zoetis in a report on Thursday, December 18th. Piper Sandler reaffirmed a “neutral” rating and set a $135.00 price objective (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Finally, Weiss Ratings downgraded shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, January 28th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $152.91.

Zoetis Price Performance

ZTS stock opened at $128.70 on Wednesday. The stock has a market capitalization of $54.33 billion, a price-to-earnings ratio of 21.38, a price-to-earnings-growth ratio of 1.92 and a beta of 0.96. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $177.00. The stock’s fifty day simple moving average is $125.61 and its 200-day simple moving average is $134.35.

Zoetis (NYSE:ZTS) last released its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Equities research analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 1.6%. Zoetis’s dividend payout ratio is 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.